Auteur V. DI BEO

  Tris disponibles Ajouter le résultat à votre sélection

  Affiner la recherche

Adherence to opioid agonist therapy predicts uptake of direct-acting antivirals in people who use drugs: Results from the French national healthcare database (the ANRS FANTASIO study)

B. ROLLAND ; C. LIONS ; V. DI BEO ; P. CARRIERI ; N. AUTHIER ; T. BARRÉ ; J. DELORME ; P. MATHURIN ; F. BAILLY ; C. PROTOPOPESCU ; F. MARCELLIN | 2022
Dans Harm Reduction Journal (Vol.19, 2022) Article : Périodique

Background: Opioid agonist therapy (OAT) is associated with reduced injection, reduced HCV transmission, and more opportunities to initiate hepatitis C virus (HCV) treatment in people who use drugs (PWUD). We aimed to study the extent to which a[...]

Plus d'info

Ajouter à la sélection

Lien externe

Cannabidiol use in France in 2022: Results from a nationwide representative sample of adults

T. BARRÉ ; E. LAHAIE ; V. DI BEO ; P. CARRIERI ; R. ANDLER ; V. NGUYEN THANH ; F. BECK | 2024
Dans Drug and Alcohol Review (Vol.43, n°5, July 2024) Article : Périodique

INTRODUCTION: Cannabidiol (CBD) is a non-intoxicating cannabis compound found in diverse commercial products worldwide. However, its use may not be fully harmless. Accordingly, it is important to document the prevalence of CBD use and user chara[...]

Plus d'info

Ajouter à la sélection

Lien externe

Exploring the medical cannabis prescribing behaviours of French general practitioners

T. BARRÉ ; H. VENTURINO ; V. DI BEO ; P. CARRIERI ; A. L. PELISSIER-ALICOT | 2023
Dans Drug and Alcohol Review (Vol.42, n°2, February 2023) Article : Périodique

Lettre à l'éditeur faisant référence à : Manoharan R., Kemper J., Young J. Exploring the medical cannabis prescribing behaviours of New Zealand physicians. Drug and Alcohol Review, 2022, Vol. 41, n° 6, p. 1355-1366. https://doi.org/10.1111/dar.[...]

Plus d'info

Ajouter à la sélection

Lien externe

Lower HCV treatment uptake in women who have received opioid agonist therapy before and during the DAA era: The ANRS FANTASIO project

T. ROJAS ROJAS ; V. DI BEO ; J. DELORME ; T. BARRÉ ; P. MATHURIN ; C. PROTOPOPESCU ; F. BAILLY ; M. COSTE ; N. AUTHIER ; M. P. CARRIERI ; B. ROLLAND ; F. MARCELLIN | 2019
Dans International Journal of Drug Policy (Vol.72, October 2019) Article : Périodique

Background: In the era of direct-acting antivirals (DAA) for the treatment of hepatitis C virus (HCV) infection, HCV treatment uptake remains insufficiently documented in key populations such as people with opioid dependence. Access to opioid ag[...]

Plus d'info

Ajouter à la sélection

A novel community-based therapeutic education program for reducing alcohol-related harms and stigma in people with alcohol use disorders: A quasi-experimental study (ETHER study)

T. BARRÉ ; C. RAMIER ; S. ANTWERPES ; M. COSTA ; M. BUREAU ; G. MARADAN ; V. DI BEO ; C. CUTARELLA ; J. LELOUTRE ; O. RICCOBONO-SOULIER ; S. HEDOIRE ; E. FROT ; F. VERNIER ; S. VASSAS-GOYARD ; S. DUFORT ; C. PROTOPOPESCU ; F. MARCELLIN ; D. CASANOVA ; M. COSTE ; P. CARRIERI | 2023
Dans Drug and Alcohol Review (Vol.42, n°3, March 2023) Article : Périodique

INTRODUCTION: Alcohol use disorder (AUD) is associated with a significant disease burden in France, where alcohol use is deeply rooted in culture. However, the treatment gap is large because of several barriers, including stigmatisation and drin[...]

Plus d'info

Ajouter à la sélection

Lien externe

Prevalence and factors associated with tobacco and cannabis co-use in France: Results from a national representative survey

T. BARRÉ ; V. DI BEO ; C. PROTOPOPESCU ; E. LAHAIE ; R. ANDLER ; V. NGUYEN THANH ; A. PASQUEREAU ; P. CARRIERI ; F. BECK | 2025
Dans Drug and Alcohol Dependence Reports (Vol.17, December 2025) Article : Périodique

Background and aims: Tobacco use is a leading global risk factor for premature mortality. Cannabis-related harms are well documented, and its co-use with tobacco may hinder smoking cessation efforts. Moreover, tobacco use may amplify certain can[...]

Plus d'info

Ajouter à la sélection

Lien externe

Recreational nitrous oxide use in France in 2022: Results from a nationwide representative sample of adults

T. BARRÉ ; E. LAHAIE ; V. DI BEO ; P. CARRIERI ; R. ANDLER ; V. NGUYEN THANH ; F. BECK | 2025
Dans Drug and Alcohol Review (Vol.44, n°4, May 2025) Article : Périodique

Introduction: The increasing heavy and sustained use of nitrous oxide (N2O) for recreational purposes in several countries is a growing public health issue, as it can cause neuropathy and other harms. Documenting recreational N2O use prevalence [...]

Plus d'info

Ajouter à la sélection

Lien externe

Screening for alcohol use in primary care: assessing French general practitioner practices

T. BARRÉ ; V. DI BEO ; P. ROUX ; A. MOURAD ; P. VERGER ; L. FRESSARD ; T. HERAULT ; J. F. BUYCK ; F. BECK ; P. CARRIERI | 2023
Dans Alcohol and Alcoholism (Vol.58, n°6, November 2023) Article : Périodique

Alcohol use is a leading risk factor for premature death and disability. To tackle this issue, more systematic and accurate screening for at-risk consumption is needed in healthcare systems, especially by general practitioners (GPs). We assessed[...]

Plus d'info

Ajouter à la sélection

Lien externe

Screening for tobacco and cannabis use by general practitioners: A French nationwide representative survey

T. BARRÉ ; V. DI BEO ; A. MOURAD ; P. CARRIERI ; G. MARADAN ; L. FRESSARD ; T. HERAULT ; J. F. BUYCK ; P. VERGER ; F. BECK | 2025
Dans International Journal of Mental Health and Addiction (Vol.23, n°5, October 2025) Article : Périodique

Screening is a crucial step in the cascade of care for people who smoke tobacco or cannabis. In France, general practitioners (GPs) are considered a pillar of tobacco control, and under National Authority of Health guidelines, they are expected [...]

Plus d'info

Ajouter à la sélection

Lien externe

Therapeutic use and other reasons to consume cannabidiol: Insight from the French and Italian contexts

D. FORTIN ; V. DI BEO ; P. CARRIERI ; T. BARRÉ | 2025
Dans Journal of Psychoactive Drugs (Vol.57, n°1, January-March 2025) Article : Périodique

Cannabidiol (CBD) has a wide spectrum of potential therapeutic use and is growing in popularity. However, there is a need to characterize users, as associated benefits and risks may differ depending on the pattern of use. This study explored the[...]

Plus d'info

Ajouter à la sélection

Lien externe

Untreated alcohol use disorder in people who inject drugs (PWID) in France: a major barrier to HCV treatment uptake (the ANRS-FANTASIO study)

T. BARRÉ ; F. MARCELLIN ; V. DI BEO ; J. DELORME ; T. ROJAS ROJAS ; P. MATHURIN ; C. PROTOPOPESCU ; F. BAILLY ; M. COSTE ; N. AUTHIER ; M. P. CARRIERI ; B. ROLLAND | 2020
Dans Addiction (Vol.115, n°3, March 2020) Article : Périodique

BACKGROUND AND AIMS: Although people who inject drugs (PWID) are the core at-risk population in the hepatitis C virus (HCV) epidemic in industrialized countries, few initiate treatment. Alcohol use disorder (AUD), common within this population, [...]

Plus d'info

Ajouter à la sélection

Lien externe